Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Lane, A. Wong, J. Burns, D. Sin, S. van Eeden (Vancouver, Canada). Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities. Eur Respir J 2010; 36: Suppl. 54, 1745

Member's Comments

No comment yet.

Related content which might interest you: Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Impact of exacerbations on COPD Source: Eur Respir Rev 2009; 19: 113-118 Year: 2010 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Antibiotics in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016